SPDR S&P Biotech ETF
Tracks the S&P Biotechnology Select Industry Index using an equal-weight methodology, tilting toward smaller biotech companies rather than mega-caps. Higher risk/reward profile than market-cap-weighted biotech funds. Sensitive to FDA approvals and clinical trial outcomes.
Performance Analysis
Maximum Drawdown History
How far the ETF has fallen from its all-time high at each point. Deeper = more painful.
Rolling Returns
Annualized returns over rolling windows. Shows the range of outcomes depending on when you invested.
Key Facts
Who Is This ETF For?
Key Risks to Consider
• Market risk: equity values can drop 30-50% in severe bear markets.
• Non-UCITS: may have unfavorable tax treatment for non-US investors (US estate tax, withholding tax).
Similar ETFs
Related Tools
Data & Methodology
Metadata sourced from official issuer documentation. Price data from Yahoo Finance (monthly adjusted close, includes reinvested dividends and splits). AUM figures are approximate and updated quarterly.